Insider trading

Period: 120 months Stock: KROS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

102 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

102 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

102 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

102 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
102 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
102 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

102 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
20 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$156.09K 4,082 at 38.24
1.4%
19 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$172.35K 4,516 at 38.16
1.5%
18 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$519.71K 13,786 at 37.70
4.5%
15 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$321.05K 8,198 at 39.16
2.7%
14 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$175.89K 4,383 at 40.13
1.4%
5 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$104.76K 2,617 at 40.03
0.9%
4 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$150.06K 3,746 at 40.06
1.2%
1 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$253.93K 6,323 at 40.16
2.0%
27 Sep 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$3.92M 95,302 at 41.17
23.6%
2 Jul 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$984.57K 23,818 at 41.34
6.4%
1 Jul 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$983.79K 23,834 at 41.28
6.3%
11 Jun 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$135.09K 2,650 at 50.98
3.3%
11 Jun 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated 2×
$50.99K 1,000 at 50.99
100%
Sold half or more
7 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 12×
$638.45K 12,796 at 49.89
3.4%
4 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$314.16K 6,619 at 47.46
1.8%
3 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$378.73K 7,895 at 47.97
2.1%
2 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$562.14K 11,529 at 48.76
3.0%
1 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$462.69K 8,812 at 52.51
2.3%
11 May 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$132.50K 2,650 at 50.00
3.6%
11 May 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated
$50.15K 1,000 at 50.15
100%
Sold half or more
4 May 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$152.86K 2,835 at 53.92
0.7%
3 May 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$2.58M 44,816 at 57.48
10.4%
12 Apr 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 4×
$318.03K 5,300 at 60.00
6.9%
12 Apr 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated 3×
$59.93K 1,000 at 59.93
100%
Sold half or more
6 Apr 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$546.84K 9,298 at 58.81
2.3%
5 Apr 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$1.63M 27,151 at 60.07
6.3%
1 Apr 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$659.70K 11,202 at 58.89
2.6%
11 Mar 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$341.75K 5,300 at 64.48
8.0%
11 Mar 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated 2×
$64.56K 1,000 at 64.56
100%
Sold half or more
4 Mar 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$645.38K 11,632 at 55.48
2.7%
3 Mar 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$707.11K 12,327 at 57.36
2.8%
2 Mar 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$629.28K 10,711 at 58.75
2.4%
1 Mar 2021
Knowles Julius Director · indirect
Sold, plan not stated 14×
$818.79K 12,979 at 63.09
2.9%
18 Feb 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$185.78K 2,944 at 63.11
0.7%
17 Feb 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$980.59K 16,061 at 61.05
3.5%
16 Feb 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$575.67K 9,612 at 59.89
2.1%
12 Feb 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$459.49K 7,468 at 61.53
1.6%
11 Feb 2021
Knowles Julius Director · indirect
Sold, plan not stated 12×
$749.44K 11,561 at 64.82
2.5%
11 Feb 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 6×
$344.02K 5,300 at 64.91
15.9%
11 Feb 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated 5×
$64.84K 1,000 at 64.84
100%
Sold half or more
17 Nov 2020
Nussbaum Ran Director · indirect
Bought 4×
$3.00M 60,000 at 50.00
2.7%
First buy on file
17 Nov 2020
Kariv Tomer Director · indirect
Bought 4×
$3.00M 60,000 at 50.00
2.7%
First buy on file
17 Nov 2020
Bought 4×
$3.00M 60,000 at 50.00
2.7%
First buy on file
13 Apr 2020
Bought 4×
$7.00M 437,499 at 16.00
24.0%
First buy on file
13 Apr 2020
Nussbaum Ran Director · indirect
Bought 4×
$7.00M 437,499 at 16.00
24.0%
First buy on file
13 Apr 2020
Kariv Tomer Director · indirect
Bought 4×
$7.00M 437,499 at 16.00
24.0%
First buy on file
13 Apr 2020
ORBIMED ADVISORS LLC Director · indirect
Bought
$6.00M 375,200 at 16.00
50.4%
First buy on file
13 Apr 2020
GORDON CARL L Director · indirect
Bought
$6.00M 375,200 at 16.00
50.4%
First buy on file
13 Apr 2020
Bought
$1.92M 120,000 at 16.00
6.3%
First buy on file
13 Apr 2020
Lazarus Alon Director · indirect
Bought
$1.92M 120,000 at 16.00
6.3%
First buy on file
Showing 51–100 of 102. ← Newer Page 2 of 3 Older →